【Generfull Biotech Co., Ltd.】Q1 2026 EPS -0.50 NTD
Generfull Biotech Co., Ltd. announced its Q1 2026 financial results, with basic EPS of -0.50 NTD, operating revenue of 0.03 billion NTD, and net loss after tax of -0.76 billion NTD.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (1727h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 08:30 (29 min after Collected)
Company Code: 6885
Company Name: Generfull Biotech Co., Ltd.
Industry: Biotechnology and Medical Industry
Year/Quarter: Q1 2026
Basic Earnings Per Share: -0.50 NTD
Operating Revenue: 0.03 Billion NTD
Net Profit After Tax: -0.76 Billion NTD
Company Name: Generfull Biotech Co., Ltd.
Industry: Biotechnology and Medical Industry
Year/Quarter: Q1 2026
Basic Earnings Per Share: -0.50 NTD
Operating Revenue: 0.03 Billion NTD
Net Profit After Tax: -0.76 Billion NTD